Exuberant Endothelial C5b-9 Formation in Recurrent and De Novo Posttransplant Thrombotic Microangiopathy.

Autor: Aiello S; Clinical Research Center for Rare Diseases 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Gastoldi S; Clinical Research Center for Rare Diseases 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Bresin E; Clinical Research Center for Rare Diseases 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Galbusera M; Clinical Research Center for Rare Diseases 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Mele C; Clinical Research Center for Rare Diseases 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Daina E; Clinical Research Center for Rare Diseases 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Santarsiero D; Clinical Research Center for Rare Diseases 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Comai G; Nephrology Dialysis and Kidney Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), Alma mater Studiorum - University of Bologna, Italy., La Manna G; Nephrology Dialysis and Kidney Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), Alma mater Studiorum - University of Bologna, Italy., Martinatto C; Clinical Research Center for Rare Diseases 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Benigni A; Clinical Research Center for Rare Diseases 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Remuzzi G; Clinical Research Center for Rare Diseases 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Noris M; Clinical Research Center for Rare Diseases 'Aldo e Cele Daccò', Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.

Publikováno v: Kidney international reports [Kidney Int Rep] 2024 Aug 22; Vol. 9 (11), pp. 3318-3323. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024).

An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome.

Autor: Gastoldi S; Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Aiello S; Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Galbusera M; Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Breno M; Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Alberti M; Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Bresin E; Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Mele C; Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Piras R; Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Liguori L; Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Santarsiero D; Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Benigni A; Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Remuzzi G; Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy., Noris M; Clinical Research Center for Rare Diseases Aldo e Cele Daccò and Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Feb 09; Vol. 14, pp. 1112257. Date of Electronic Publication: 2023 Feb 09 (Print Publication: 2023).

C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19.

Autor: Aiello S; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy; and., Gastoldi S; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy; and., Galbusera M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy; and., Ruggenenti P; Unit of Nephrology and Dialysis, Azienda Socio-Sanitaria Territoriale (ASST) Papa Giovanni XXIII, Bergamo, Italy., Portalupi V; Unit of Nephrology and Dialysis, Azienda Socio-Sanitaria Territoriale (ASST) Papa Giovanni XXIII, Bergamo, Italy., Rota S; Unit of Nephrology and Dialysis, Azienda Socio-Sanitaria Territoriale (ASST) Papa Giovanni XXIII, Bergamo, Italy., Rubis N; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy; and., Liguori L; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy; and., Conti S; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy; and., Tironi M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy; and., Gamba S; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy; and., Santarsiero D; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy; and., Benigni A; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy; and., Remuzzi G; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy; and., Noris M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy; and.

Publikováno v: Blood advances [Blood Adv] 2022 Jan 08; Vol. 6 (3), pp. 866-881.

Risdiplam treatment has not led to retinal toxicity in patients with spinal muscular atrophy.

Autor: Sergott RC; Department of Neuro-Ophthalmology, Wills Eye Hospital, Philadelphia, USA.; Annesley EyeBrain Center, Thomas Jefferson University, Philadelphia, USA., Amorelli GM; Paediatric Neurology and Nemo Center, Catholic University and Policlinico Gemelli, Rome, Italy., Baranello G; The Dubowitz Neuromuscular Centre, NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health University College London, & Great Ormond Street Hospital Trust, London, UK.; Developmental Neurology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy., Barreau E; Institute of Myology, Paris, France., Beres S; Department of Neurology, Department of Ophthalmology, Stanford University, Palo Alto, California, USA., Kane S; Columbia University Medical Center, New York, USA., Mercuri E; Paediatric Neurology and Nemo Center, Catholic University and Policlinico Gemelli, Rome, Italy., Orazi L; Paediatric Neurology and Nemo Center, Catholic University and Policlinico Gemelli, Rome, Italy., SantaMaria M; Annesley EyeBrain Center, Thomas Jefferson University, Philadelphia, USA., Tremolada G; Neuro-Ophthalmology Center, Ophthalmology Department, IRCCS Istituto Auxologico Italiano, Milan, Italy., Santarsiero D; Neuro-Ophthalmology Center, Ophthalmology Department, IRCCS Istituto Auxologico Italiano, Milan, Italy., Waskowska A; Department of Developmental Neurology, Medical University of Gdańsk, Gdańsk, Poland., Yashiro S; Department of Ophthalmology, National Center for Global Health and Medicine (NCGM), Tokyo, Japan., Denk N; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Fürst-Recktenwald S; Pharma Development Neurology, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Gerber M; Pharma Development, Safety, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Gorni K; PDMA Neuroscience and Rare Disease, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Jaber B; Pharma Development, Safety, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Jacobsen B; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Mueller L; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Nave S; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Scalco RS; Pharma Development Neurology, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Marzoli SB; Neuro-Ophthalmology Center, Ophthalmology Department, IRCCS Istituto Auxologico Italiano, Milan, Italy.

Publikováno v: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2021 Jan; Vol. 8 (1), pp. 54-65. Date of Electronic Publication: 2020 Nov 24.

Typological and Experimental Investigation on the Adobe Buildings of Aliano (Basilicata, Italy)

Autor: Liberatore D., Spera G., Mucciarelli M., Gallipoli M.R., Santarsiero D., Tancredi C., Masini N., Racina V., Capriuoli A., Cividini A., Tedeschi C.

Publikováno v: SAHC'2006-Structural Analysis of Historical Constructions, New Delhi, India, 2006
info:cnr-pdr/source/autori:Liberatore D., Spera G., Mucciarelli M., Gallipoli M.R., Santarsiero D., Tancredi C., Masini N., Racina V., Capriuoli A., Cividini A., Tedeschi C./congresso_nome:SAHC'2006-Structural Analysis of Historical Constructions/congresso_luogo:New Delhi, India/congresso_data:2006/anno:2006/pagina_da:/pagina_a:/intervallo_pagine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f76e059738ff0d0dc49d8103bffa568b
http://hdl.handle.net/11573/204207